SNYR
Synergy CHC Corp.
NASDAQ · Healthcare · Medical - Distribution · US
$0.10
−6.82%Year over year
Reported trailing growth
- Revenue
- -17.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +20.2%
- Operating cash flow
- +20.2%
Forward estimates
Based on analyst estimates
- Revenue
- +15.5%
- EBITDA
- +182.7%
- EPS
- +103.1%
Three-year CAGR
- Revenue
- -7.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +46.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026